Delivery Order SPE2DB22D3004-SPE2DB25FNL67
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$9.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $40,553.58 firm fixed-price contract is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of April 29, 2025 and is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,717.68 contract is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV infection. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,290.24 firm fixed-price contract is for the delivery of Biktarvy 50-200-25 mg tablets, a specialty HIV medication, to support military and federal healthcare programs. The contract has an ultimate completion date of April 17, 2023 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,690.18, is for the provision of Biktarvy 50-200-25 mg tablet, a medication used in the treatment of HIV. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $36,218.78 firm fixed-price delivery order contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $109,586.33 firm fixed-price contract is for the supply of the HIV medication Biktarvy 50-200-25 mg tablets. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,626.45 firm fixed-price contract is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has a ceiling value of $25,971.14 and is a firm fixed-price, non-set-aside contract. It has an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV infection. The delivery order has a ceiling value of $6,192.60 and a period of performance through April 1, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,922.18 firm fixed-price delivery order is for the medication Biktarvy, a treatment for HIV. The contract has a completion date of December 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary...